Literature DB >> 30969502

Can Immune Checkpoint Inhibitors Keep JC Virus in Check?

Igor J Koralnik1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30969502     DOI: 10.1056/NEJMe1904140

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

1.  Checkpoint inhibitors and progressive multifocal leukoencephalopathy: friends of foes?

Authors:  Daniele Focosi; Marco Tuccori; Fabrizio Maggi
Journal:  Ann Transl Med       Date:  2019-12

Review 2.  Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML).

Authors:  Amir Khalili; Michael Craigie; Martina Donadoni; Ilker Kudret Sariyer
Journal:  J Neuroimmune Pharmacol       Date:  2019-08-27       Impact factor: 4.147

3.  Progressive Multifocal Leukoencephalopathy in B-CLL Successfully Treated With Venetoclax and Pembrolizumab.

Authors:  Jacopo Olivieri; Pietro Lauzzana; Stefano Volpetti; Marco Girgenti; Giuseppe Petruzzellis; Anna Candoni; Renato Fanin
Journal:  Hemasphere       Date:  2022-05-31

4.  Pneumocystis Pneumonia: Checkpoint Inhibition to the Rescue?

Authors:  Julian Better; Ulrich Matt
Journal:  Am J Respir Cell Mol Biol       Date:  2020-06       Impact factor: 6.914

Review 5.  JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review.

Authors:  Vijay Harypursat; Yihong Zhou; Shengquan Tang; Yaokai Chen
Journal:  AIDS Res Ther       Date:  2020-07-06       Impact factor: 2.250

Review 6.  Coronavirus infection and immune system: An insight of COVID-19 in cancer patients.

Authors:  Alice Indini; Erika Rijavec; Michele Ghidini; Claudia Bareggi; Monica Cattaneo; Barbara Galassi; Donatella Gambini; Francesco Grossi
Journal:  Crit Rev Oncol Hematol       Date:  2020-07-09       Impact factor: 6.312

7.  Ineffective treatment of PML with pembrolizumab: Exhausted memory T-cell subsets as a clue?

Authors:  Marc Pawlitzki; Tilman Schneider-Hohendorf; Leoni Rolfes; Sven G Meuth; Heinz Wiendl; Nicholas Schwab; Oliver M Grauer
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-10-09

8.  Pembrolizumab as a treatment for PML? Waiting for Godot.

Authors:  Renaud A Du Pasquier
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-10-09

Review 9.  On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19.

Authors:  Thilo Gambichler; Judith Reuther; Christina H Scheel; Jürgen Christian Becker
Journal:  J Immunother Cancer       Date:  2020-07       Impact factor: 13.751

10.  Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers.

Authors:  Jia Luo; Hira Rizvi; Jacklynn V Egger; Isabel R Preeshagul; Jedd D Wolchok; Matthew D Hellmann
Journal:  Cancer Discov       Date:  2020-05-12       Impact factor: 38.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.